Skip to main content

Bluestone Jewellery and Lifestyle Limited — ≥1% Shareholders

Every non-promoter shareholder owning 1% or more of Bluestone Jewellery and Lifestyle Limited, parsed from the latest quarterly Shareholding Pattern filing. Curated holders link to a tracked profile; mystery holders are flagged.

0 curated 28 mystery Quarter: Mar 2026

Institutional intelligence for Bluestone Jewellery and Lifestyle Limited

Cross-view mutual fund activity and super-investor shareholding · Mar 2026 SHP.

Holder Type % of company Shares Value (₹ Cr)
GAURAV SINGH KUSHWAHA individual 16.07% 2,44,65,127
ACCEL INDIA III (MAURITIUS) LTD fii 8.73% 1,32,90,055
SBI LIFE INSURANCE CO. LTD dii 5.00% 76,11,320
NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA CON dii 4.03% 61,29,054
MIH INVESTMENTS ONE B.V. fii 3.99% 60,80,439
SUNIL KANT MUNJAL individual 3.71% 56,50,000
360 ONE SPECIAL OPPORTUNITIES FUND - SERIES 12 dii 3.22% 48,98,848
AMANSA HOLDINGS PRIVATE LIMITED fii 3.16% 48,09,307
IE VENTURE INVESTMENT FUND II dii 2.70% 41,12,680
PEAK XV PARTNERS GROWTH INVESTMENTS IV fii 2.67% 40,71,580
ACCEL INDIA VII (MAURITIUS) LIMITED fii 2.48% 37,67,870
STEADVIEW CAPITAL MAURITIUS LIMITED fii 2.37% 36,04,943
KALAARI CAPITAL PARTNERS II LLC fii 2.32% 35,36,990
ACCESS INDIA CAPITAL dii 1.92% 29,26,410
PRATITHI GROWTH FUND I dii 1.90% 28,98,944
IVYCAP VENTURES TRUST dii 1.72% 26,18,110
RB INVESTMENTS PTE. LTD. fii 1.72% 26,13,955
IRON PILLAR FUND I LTD dii 1.71% 26,09,925
IVYCAP VENTURES TRUST FUND II dii 1.67% 25,40,390
360 ONE LARGE VALUE FUND- SERIES 13 dii 1.63% 24,80,044
ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED A/C dii 1.61% 24,48,026
GOLDMAN SACHS FUNDS - GOLDMAN SACHS INDIA EQUITY P fii 1.22% 18,63,453
KAMATH ASSOCIATES individual 1.09% 16,59,376
NKSQUARED individual 1.09% 16,59,376
IVYCAP VENTURES TRUST FUND III dii 1.09% 16,59,376
360 ONE SPECIAL OPPORTUNITIES FUND - SERIES 11 dii 1.08% 16,39,036
GANESH KRISHNAN individual 1.06% 16,16,070
IRON PILLAR INDIA FUND I dii 1.03% 15,68,052

Shareholding data sourced from NSE/BSE regulatory filings. Not investment advice. See our disclaimer and methodology.